Adaptin Bio (APTN) Return on Assets (2023 - 2026)

Adaptin Bio's Return on Assets history runs 4 years deep, the most recent figure standing at 0.09% for Q1 2026.

• In Q1 2026, Return on Assets fell 6.0% year-over-year to 0.09%; the TTM figure through Mar 2026 stood at 0.09% (down 6.0% YoY), while the FY2025 annual figure was 0.12%, up 14.0% from the prior year.
• Return on Assets came in at 0.09% for Q1 2026 at Adaptin Bio, down from 0.07% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.02% in Q2 2025 to a low of 71.42% in Q3 2024.
• A 4-year average of 12.01% and a median of 0.17% in 2024 frame the typical range for Return on Assets.
• Across the five-year window, Return on Assets jumped 7139 bps in 2025 and slipped 6 bps in 2026, its largest moves.
• Adaptin Bio's Return on Assets stood at 2.03% in 2023, then jumped by 87 bps to 0.26% in 2024, then surged by 75 bps to 0.07% in 2025, then sank by 33 bps to 0.09% in 2026.
• According to Business Quant data, Return on Assets over the past three periods registered 0.09%, 0.07%, and 0.04% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison